Antibiotics Increase Mouse Susceptibility to Dengue, West Nile, and Zika

The drugs’ disruption of the microbiome makes a subsequent flavivirus infection more severe.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

West Nile virusFLICKR, CDC/CYNTHIA GOLDSMITHIt’s a truism that antibiotics won’t help treat a viral infection. And it now appears they could even hurt, making viral infections more severe. In a study out today (March 27) in Cell Reports, researchers found that when mice were treated with antibiotics and then infected with pathogens in the flavivirus family (which includes Zika, West Nile, and dengue), they fared far worse than their untreated counterparts. The authors suggest the antibiotics may have compromised the animals’ immunity by altering their microbiomes.

“The clinical phenotype of the animals when they got antibiotics, compared to those that didn’t, was pretty dramatic. They got a lot sicker and then they died, ultimately, of West Nile encephalitis,” says Michael Diamond, an immunobiology researcher at Washington University School of Medicine in St. Louis who led the study. “And this was true not just for West Nile virus, but also for two related viruses in the family, Zika virus and also dengue virus.”

While the idea that antibiotics can modulate antiviral immunity is not new, an interesting aspect of this study is that it suggests a mechanism for that effect, says Paulo Verardi, a virologist at the University of Connecticut who was not involved in the study—namely, that changes in gut microbes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Shawna Williams

    Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in biochemistry from Colorado College and a graduate certificate and science communication from the University of California, Santa Cruz.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours